By Topic

Identification of Mild Alzheimer's Disease through automated classification of structural MRI features

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

8 Author(s)
Diciotti, S. ; Dept. of Clinical Pathophysiology, Univ. of Florence, Florence, Italy ; Ginestroni, A. ; Bessi, V. ; Giannelli, M.
more authors

The significant potential for early and accurate detection of Alzheimer's disease (AD) through neuroimaging data is becoming increasingly attractive in view of the possible advent of drugs which are able to modify or delay disease progression. In this paper, we aimed at developing an effective machine learning scheme which leverages structural magnetic resonance imaging features in order to identify and discriminate individuals affected by mild AD on a single subject basis. Selected features included one- and two-way combinations of subcortical and cortical volumes as well as cortical thickness and curvature of numerous brain regions which are known to be vulnerable to AD. Additionally, several feature combinations were fed into support vector machines (SVMs) as well as Naïve Bayes classifiers in order to compare scheme accuracy. The most efficient combination of features and classification scheme, which employed both subcortical and cortical volumes feature vectors and a SVM classifier, was able to distinguish mild AD patients from healthy controls with 86% accuracy (82% sensitivity and 90% specificity). While this investigation is of preliminary nature, and further efforts are currently underway towards automated feature selection, best classifier determination and parameter optimization, our results appear very promising in terms of automated high-accuracy discrimination of disease stages which cannot easily be distinguished though routine clinical investigation.

Published in:

Engineering in Medicine and Biology Society (EMBC), 2012 Annual International Conference of the IEEE

Date of Conference:

Aug. 28 2012-Sept. 1 2012